Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
429
-
Total 13F shares, excl. options
-
52M
-
Shares change
-
+2.21M
-
Total reported value, excl. options
-
$8.81B
-
Value change
-
+$356M
-
Put/Call ratio
-
0.43
-
Number of buys
-
208
-
Number of sells
-
-191
-
Price
-
$169.31
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2022
502 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2022.
REPLIGEN CORP - COMMON STOCK (RGEN) has 429 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52M shares
of 56.2M outstanding shares and own 92.57% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.12M shares), VANGUARD GROUP INC (5.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.07M shares), SANDS CAPITAL MANAGEMENT, LLC (1.78M shares), WCM INVESTMENT MANAGEMENT, LLC (1.6M shares), STATE STREET CORP (1.6M shares), Invesco Ltd. (1.57M shares), BROWN CAPITAL MANAGEMENT LLC (1.45M shares), Artisan Partners Limited Partnership (1.17M shares), and MACQUARIE GROUP LTD (1.1M shares).
This table shows the top 429 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.